20 US states sue Trump admin: Row erupts over 'illegal' sharing of medicaid data; release targeted non-citizens
California attorney general Rob Bonta announced Tuesday that the state, along with 19 other attorneys general, is suing the federal government over the release of Medicaid data to deportation officials.
The lawsuit claims that the Trump administration violated federal privacy laws when it handed over the private health information of millions of enrollees to deportation officials last month, reported AP.
The data, which included names, addresses, Social Security numbers, immigration status and claims records, was shared by order of advisors to health secretary Robert F Kennedy Jr. It covered individuals in California, Illinois, and both Washington State and Washington, DC.
These states allow noncitizens to enrol in Medicaid programs funded solely by state taxpayer dollars. The sharing of data came as immigration enforcement increased efforts nationwide.
A spokesperson for the department of health and human services (HHS), Andrew Nixon, defended the move, saying, 'HHS acted entirely within its legal authority- and in full compliance with all applicable laws- to ensure that Medicaid benefits are reserved for individuals who are lawfully entitled to receive them.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
India Today
10 hours ago
- India Today
20 states sue Trump administration over sharing Medicaid data with immigration
The Trump administration violated federal privacy laws when it turned over Medicaid data on millions of enrollees to deportation officials last month, California Attorney General Rob Bonta alleged on Tuesday, saying he and 19 other states' attorneys general have sued over the secretary Robert F. Kennedy Jr.'s advisers ordered the release of a dataset that includes the private health information of people living in California, Illinois, Washington state, and Washington, D.C., to the Department of Homeland Security, The Associated Press first reported last month. All of those states allow non-U.S. citizens to enroll in Medicaid programs that pay for their expenses using only state taxpayer unusual data sharing of private health information, including addresses, names, social security numbers, immigration status, and claims data for enrollees in those states, was released to deportation officials as they accelerated enforcement efforts across the country. The data could be used to help the Department of Homeland Security locate migrants in its mass deportation campaign, experts said. Bonta said the Trump administration's data release violates federal health privacy protection laws, including the Health Insurance Portability and Accountability Act (HIPAA).'This is about flouting seven decades of federal law policy and practice that have made it clear that personal healthcare data is confidential and can only be shared in certain narrow circumstances that benefit the public's health or the Medicaid program,' Bonta said during a news conference on Trump administration has sought to arm deportation officials with more data on immigrants. In May, for example, a federal judge refused to block the Internal Revenue Service from sharing immigrants' tax data with Immigration and Customs Enforcement to help agents locate and detain people living without legal status in the move to shore up the federal government's data on immigrant Medicaid enrollees appears to have been set in motion in May, when the Centers for Medicare and Medicaid Services announced it would be reviewing some states rolls to ensure federal funds have not been used to pay for coverage for people with 'unsatisfactory immigration status.'As part of the review, CMS asked California, Washington and Illinois to share details about non-U.S. citizens who have enrolled in their state's Medicaid program, according to a June 6 memo signed by Medicaid Deputy Director Sara Vitolo that was obtained by the AP. The memo was written by several CMS officials under Vitolo's supervision, according to sources familiar with the officials attempted to fight the data sharing request from Homeland Security, saying that to do so would violate federal laws, including the Social Security Act and the Privacy Act of 1974, according to the legal arguments outlined in the memo were not persuasive to Trump appointees at HHS, which oversees the Medicaid days after the memo was sent, on June 10, HHS officials directed the transfer of 'the data to DHS by 5:30 ET today,' according to email exchanges obtained by is 'aggressively cracking down on states that may be misusing federal Medicaid funds,' agency spokesman Andrew Nixon said in a statement. The agency has not provided details on DHS' role in the effort. Nixon also defended the legality of releasing the data to DHS.'HHS acted entirely within its legal authority – and in full compliance with all applicable laws – to ensure that Medicaid benefits are reserved for individuals who are lawfully entitled to receive them,' he said in the of Democratic members of Congress — in both the House and Senate — have sent letters to the involved agencies, demanding that data sharing cease and that Homeland Security destroy the information it has received so far. - EndsMust Watch
Time of India
15 hours ago
- Time of India
Centene stock crashes 40% as enrollments drop and costs surge, 2025 outlook pulled
Centene stock crashes as company pulls 2025 outlook and warns of rising costs- Centene stock plunged to its lowest point since 2017 after the healthcare giant pulled its 2025 earnings guidance and revealed unexpected enrollment trends and rising patient costs. The managed-care company, which primarily provides Medicaid and Affordable Care Act (ACA) plans, now expects 2025 adjusted earnings to be $2.75 per share lower than previously forecasted—wiping out about $1.8 billion from its outlook. This sudden shift triggered panic on Wall Street, causing Centene (CNC) shares to lose nearly a third of their value in early trading, making it the worst-performing stock in the S&P 500 on Wednesday. Why did Centene pull its 2025 outlook? Centene's decision to scrap its full-year guidance was driven by new internal data from 22 of its 29 ACA marketplaces. The data showed that membership growth was slower than expected, and more critically, the health status of new enrollees was significantly worse than anticipated. This mismatch impacted the company's risk adjustment revenue assumptions—a key factor in calculating federal reimbursements under ACA programs. As a result, Centene warned that these unexpected shifts would have a $1.8 billion negative impact on next year's earnings. How much will Centene earnings drop in 2025? Back in April, Centene had forecast 2025 adjusted earnings per share (EPS) of over $7.25. But after analyzing the new risk pool data, the company slashed its forecast by $2.75 per share , bringing the revised estimate closer to $4.50 EPS . This is a massive revision for a company that has been a dominant player in Medicaid and ACA coverage. It also reflects deeper structural challenges in the healthcare insurance sector—especially around pricing plans to cover sicker-than-expected patients. Live Events What's happening with Centene's enrollments and federal reimbursements? Centene reported that enrollment growth has slowed sharply. Meanwhile, the health profile—or morbidity rate—of many of its newly enrolled members is far worse than anticipated. This means patients are using more care, which increases costs, while risk adjustment payments from the federal government may not be enough to offset that spending. To adapt, Centene is now refiling its 2026 rate proposals, adjusting for a 'higher projected baseline of Marketplace morbidity,' a clear signal that this trend isn't just temporary. How are analysts reacting to Centene's surprise guidance withdrawal? The market's reaction was swift and brutal. Centene stock sank to levels not seen since 2017, and several analysts quickly downgraded the stock. Both Jefferies and UBS lowered their price targets, citing concerns over earnings visibility, growing uncertainty in ACA margins, and potential further deterioration in enrollment quality. This isn't the first time a major healthcare provider has run into trouble this year. Earlier in 2025, UnitedHealth Group (UNH) also trimmed its forecast due to higher-than-expected medical costs. Centene stock sees sharpest fall in years Centene Corp. (CNC) is currently trading around $34.42 , marking a massive drop of nearly 39% in a single day . This crash came after the company pulled its 2025 earnings guidance due to rising costs and slower enrollment growth. Earlier in the day, the stock hit an intraday low of $33.97 , its lowest level in over eight years . Recent performance snapshot: Metric Value Latest Price $34.42 Day's High $43.14 Day's Low $33.97 Opening Price $37.44 Volume ~53.8 million shares YTD Performance Approx. -15% 52-Week Range $33.97 – $80.59 Forward P/E Ratio Around 4.7 Why is Centene stock falling so fast? Outlook withdrawn : Centene pulled its full-year 2025 earnings forecast, citing higher-than-expected patient illness and a sharp slowdown in ACA enrollment growth. Earnings cut : The company warned of a $2.75 per share cut , translating to a $1.8 billion impact on its 2025 results. Downgrades : Analysts reacted quickly, downgrading the stock and lowering price targets due to rising uncertainty in ACA-related margins and risk pool assumptions. What does this mean for the healthcare insurance industry? Centene's situation reflects a broader challenge facing companies in the Affordable Care Act and Medicaid markets. As patient health trends shift and federal reimbursement models lag behind, insurers are struggling to balance premium pricing, risk pool assumptions, and real-world costs. The company's move to re-price its 2026 plans shows it's taking corrective action, but it also underlines how volatile the business can be when market assumptions break down. Can Centene bounce back? Centene's leadership didn't offer a revised full-year forecast but made it clear that the 2025 results will fall short. Investors will now be watching closely to see how the company adjusts its future pricing and risk models—and whether it can restore confidence. For now, though, the sharp drop in Centene stock reflects deeper anxiety across the healthcare insurance sector, particularly among those who rely heavily on ACA marketplaces. With policy changes and patient trends evolving quickly, this may not be the last shake-up we see in the industry. FAQs: What caused Centene stock to drop in 2025? Centene stock dropped after it pulled its 2025 earnings forecast due to lower enrollments and higher patient costs. How much earnings did Centene cut from its 2025 outlook? Centene slashed its 2025 EPS by $2.75, wiping out $1.8 billion in projected earnings.
Hindustan Times
17 hours ago
- Hindustan Times
UK's Princess Kate opens up about ‘brave face' during cancer treatment
Britain's Princess of Wales Kate Middleton said on Wednesday she had to put on a 'brave face' throughout and following her cancer treatment last year. She also described the ordeal as a life-changing experience. Britain's Kate, Princess of Wales, speakes during a visit to the RHS's Wellbeing Garden at Colchester Hospital in Essex, England, on Wednesday. (AP) Kate Middleton, 43, announced in March 2024 that she would undergo a course of chemotherapy after tests taken following major abdominal surgery revealed that an unspecified form of cancer had been present. Kate Middleton completed the course of treatment in September, and said earlier this year she was in remission. "You put on a sort of brave face, stoicism through treatment, treatment's done, then it's like, 'I can crack on, get back to normal', but actually the phase afterwards is really... difficult," news agency Reuters quoted Kate as saying during a visit to a hospital in Essex, southeast England. Speaking to staff, patients and volunteers at the hospital, the UK Princess stressed on the importance of support after treatment, noting that while patients may no longer be under clinical care, they often still struggle to "function normally at home" as they once did. Kate described the cancer diagnosis and treatment as "life-changing" for both patients and their loved ones, according to PA Media, adding: "It's a rollercoaster, it's not one smooth plain". The princess has been gradually resuming her public royal role but missed the Royal Ascot horse racing event last month, with a royal source citing her need for balance following her cancer treatment.
